Generation time is the time required for a quiescent cell to
complete a cycle in cell division and give rise to 2 daughter cells.
Malignant cells usually have a shorter generation time than
nonmalignant cells from the same tissue, and there usually are a smaller percentage of cells in G0 (resting phase).
The slowing in growth rate is likely related to exhaustion of
the supply of nutrients and O2 for the rapidly expanding tumor. Small tumors have a greater percentage of actively dividing cells than do large tumors. Cellular kinetics of particular tumors is an important consideration in the design of anti neoplastic drug regimens and may influence the dosing schedules and timing intervals of treatment.
Many anti neoplastic drugs are effective only if cells are
actively dividing, and some drugs work only during a specific phase of the cycle and thus require prolonged administration to catch dividing cells during the phase of maximal sensitivity. Cell cycle
synthetic phase (12 h to a few days); S = DNA synthesis (usually 2 to 4 h); G2 = post-DNA synthesis (2 to 4 h)a tetraploid quantity of DNA is found within cells; M1 = mitosis (1 to 2 h). Molecular Abnormalities Genetic mutations are responsible for the generation of cancer cells. These mutations alter the quantity or function of protein products that regulate cell growth and division and DNA repair. 4 major categories of mutated genes are oncogenes and tumor suppressor genes : proto-oncogenes tumor suppressor genes regulate programmed cell death (apoptosis) genes DNA repair genes ONCOGENES These are abnormal forms of normal genes (proto-oncogenes) that regulate various aspects of cell growth. Mutation of these genes may result in direct and continuous stimulation of the pathways eg : - intracellular signal transduction pathways, transcription factors, secreted growth factors that control cellular growth and division, DNA repair, angiogenesis, and other physiologic processes. Oncogen . . . cont Specific oncogenes may have important implications for diagnosis, therapy, and prognosis (see individual discussions under the specific cancer type).
Oncogenes typically result from :
- acquired somatic cell mutations secondary to point mutations (eg, from chemical carcinogens), - gene amplification (eg, an increase in the number of copies of a normal gene), or - translocations.
Occasionally, mutation of genes results in inheritance of a
cancer predisposition, as in the inheritance of BRCA1 or BRCA2 in families with a high incidence of breast or ovarian cancer. Gene amplification, Deletion, Rearrangement , Mutation ONCOGENES . . . cont There are > 100 known oncogenes that may contribute to human neoplastic transformation. For example, the ras gene encodes the Ras protein, which regulates cell division. Mutations may result in the inappropriate activation of the Ras protein, leading to uncontrolled cell growth and division. In fact, the Ras protein is abnormal in about 25% of human cancers. Other oncogenes have been implicated in specific cancers. These include : Her2/neu (breast cancer) bcr-abl (chronic myelocytic leukemia, B-cell acute lymphocytic leukemia) C-myc (Burkett's lymphoma) N-myc (small cell lung cancer, neuroblastoma) Tumor suppressor genes Genes that brakes the cell proliferation.
Genes such as the p53 gene play a role in normal cell
division and DNA repair and are critical for detecting inappropriate growth signals in cells.
If these genes, as a result of inherited or acquired
mutations, become unable to function, genetic mutations in other genes can proceed unchecked, leading to neoplastic transformation. Chromosomal abnormalities Gross chromosomal abnormalities can occur through deletion, translocation, or duplication. If these alterations activate or inactivate genes that result in a proliferative advantage over normal cells, then a tumor may develop.
Chromosomal abnormalities occur in certain human
cancers.
In some congenital diseases (Bloom syndrome, Fanconi
anemia, Down syndrome), DNA repair processes are defective and chromosomes break easily, putting children at high risk of developing acute leukemia and lymphomas.ccur in certain human cancers Other influences Most cancers likely involve several of the mechanisms described above that lead to neoplastic conversion.
For example, the development of tumor in familial polyposis
takes place through a sequence of genetic events: epithelium hyperproliferation (loss of a suppressor gene on chromosome , early adenoma (change in DNA methylation), intermediate adenoma (overactivity of the ras oncogene), late adenoma (loss of a suppressor gene on chromosome , and finally, cancer(loss of a gene on chromosome )
Further genetic changes may be required for metastasis.
Other influences Most cancers likely involve several of the mechanisms described above that lead to neoplastic conversion.
For example, the development of tumor in familial polyposis
takes place through a sequence of genetic events: epithelium hyperproliferation (loss of a suppressor gene on chromosome , early adenoma (change in DNA methylation), intermediate adenoma (overactivity of the ras oncogene), late adenoma (loss of a suppressor gene on chromosome , and finally, cancer(loss of a gene on chromosome )
Further genetic changes may be required for metastasis.
Telomeres are nucleoprotein complexes that cap the ends of chromosomes and maintain their integrity. In normal tissue, telomere shortening (with aging) results in a finite limit in cell division. The enzyme telomerase provides for telomere synthesis and maintenance; thus telomerase may potentially allow for cellular immortality. Activation of telomerase in tumors allows continuous proliferation of tumors. TELOMERES . . cont
are short repeated sequences of DNA
TTAGGG (linear end of chromosomes) and are important in : ensuring THE COMPLETE REPLICATION of chromosome ends protecting chromosomal termini from fusion and degradation Telomerase The sequences are formed by a special RHIBONUCLEOPROTEIN --- TELOMERASE
Enzym that stabilized
Telomere length by adding to the ends of chromosomes
Activities of telomerase repressed by REGULATORY
PROTEINS ---- RESTRICT Telomere elongation TELOMERASE ACTIVITY : expressed in GERM CELL present at low levels in STEM CELLS absent in most SOMATIC CELLS
Somatic cells replicate
Small section of the telomere is not duplicated Telomeres shorten Signal in growth checkpoint Cell become SENESCENT IMMORTAL CELLS
Telomeresase REACTIVATED
Telomeres are NOT SHORTENED
Telomeres ELONGATION ----------- TUMOR /
NEOPLASM in cellular aging : after a fixed number of divisions, normal cells become arrested in a terminally no dividing CELLULAR SENESCENCE How normal cells can count their divisions is not known, but noted that in cell division there is some shortening specialized structure called : TELOMERES Once the telomeres are shortened beyond a certain point the lost telomere function leads to end-to-end chromosome fusion and death Thus, telomere shortening is believed to be clock that Count divisions In germ cells, telomere shortening is prevented by the sustained function of the enzyme telomerase ---- Explaining the ability of these cells to self replicate This enzyme is absent from most somatic cells, and hence they suffer progressive lost of telomeres A recent study, shown that introduction of telomerase into normal human cells causes considerable extension of their life span ------- thus supporting the hypothesis that telomerase loss is causally associated with loss of replication ability. If loss of telomerase is the basis of the finite life span of cells, how do cancer cells continue to divide indefinitely ? The telomerase, hypothesis of cellular ageing would predict that in addition to the loss of normal growth regulatory influences, cancer cells must find a way to prevent telomere shortening ----- an obvious mechanism to accomplish this might be to reactivate telomerase Telomerase actitivity has been detected in the vast majority of human tumors, and in those that lack of telomerase, other telomere-lenghthening mechanisms have been found. It could be hypothesized : that telomere shortening is a tumor-suppresive mechanism Carcinogenesis Thank you
Machine Learning Predicts 5-Chloro-1 - (2 - Phenylethyl) - 1h-Indole-2,3-Dione As A Drug Target For Fructose Bisphosphate Aldolase in Plasmodium Falciparum
International Journal of Innovative Science and Research Technology